Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PSPC1 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
mRNA | CLK1 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
mRNA | BYSL | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |
mRNA | PCK1 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
mRNA | ZNF562 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
mRNA | BBC3 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
mRNA | PEX1 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |
mRNA | HSPB6 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |
mRNA | HSPB7 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.01 |
mRNA | SYNPO | CTRPv2 | pan-cancer | AAC | -0.097 | 0.01 |